Position in TGTX
as of Dec 31, 2023
· filed Jan 8, 2024
Position Value
$427,000
+$218,000 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
6 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2023Bartlett & Co. LLC holds $1,920,237 across 16 Biotechnology names. TGTX ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $694,860 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
This page
|
25,000 | $427,000 | |
| 3 | FTRE |
Fortrea Holdings Inc.
|
9,420 | $328,758 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
344 | $302,131 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
200 | $81,378 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
1,500 | $32,190 | |
| 7 | MRNA |
Moderna, Inc.
|
310 | $30,829 | |
| 8 | TECH |
BIO-TECHNE Corp
|
172 | $13,271 |
All Filings in TGTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2023-12-31 | $427,000 | 25,000 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $209,000 | 25,000 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $621,000 | 25,000 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $376,000 | 25,000 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $295,750 | 25,000 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $148,000 | 25,000 | Shares | Sole | 2022-10-17 | |
| No filing history on record for this holder in this stock. | ||||||